Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/1989
08/08/1989US4855238 Recombinant gamma interferons having enhanced stability and methods therefor
08/08/1989US4855136 Therapeutic composition and method
08/08/1989CA1258264A1 .beta.-METHYLENETHIOPHENETHANAMINES
08/02/1989EP0326134A1 4-Amino-2,3-disubstituted-6,7-dihydro-5H-1-pyridine derivatives, process for their preparation and medicaments containing them
08/02/1989EP0326106A2 Alkylene diamines
08/02/1989EP0326075A2 Heparin-binding brain mitogens
08/02/1989CN1034366A Non-peptidic renin inhibitors
08/02/1989CN1034313A Process for preparation of aloe products
08/01/1989US4853410 Hydroxyacetic acid derivatives for the treatment of diabetic complications
08/01/1989US4853407 Aminoethylcysteine derivatives
08/01/1989US4853403 3-phenylthiomethylstyrene derivative, process for preparing the same, and antiallergic agent and tyrosinekinase inhibiting agent containing the same
08/01/1989US4853393 Hypotensive agents, anticoagulants
08/01/1989US4853390 (2-Haloergolinyl)-N'-N'-diethylurea compounds useful as medicinal agents E.G., as neuroleptics
08/01/1989US4853376 Gastrointestinal disorders
08/01/1989CA1258148A1 Process for the preparation of n-alkylated dipeptides and their esters
07/1989
07/27/1989WO1989006692A1 Method of treating tumor cells by inhibiting growth factor receptor function
07/27/1989WO1989006651A1 1h-indazole-3-acetic acids as aldose reductase inhibitors
07/27/1989WO1989006539A1 Process for preparation of aloe products
07/27/1989WO1989006538A1 Process for producing a therapeutically active ingredient, in particular for cicatrization or for treatment in geriatry, and a therapeutic preparation containing said active ingredient
07/27/1989WO1989006536A1 Growth inhibiting agent and the use thereof
07/27/1989DE3902157A1 Amphiregulin, verfahren zu dessen herstellung und pharmazeutische mittel Amphiregulin, process for its preparation and pharmaceutical compositions
07/26/1989EP0325375A1 1H-indazole-3-acetic acids as aldose reductase inhibitors
07/26/1989EP0325263A1 Tetrahydropyridine derivatives
07/26/1989EP0324947A1 Synergistic combination of decarboxylase inhibitors and L-dopa pellets
07/26/1989EP0324815A1 New 9-substituted carbocycline derivatives, process for manufacturing them and their use as drugs
07/25/1989US4851440 Leukotriene antagonists, processes for the preparation thereof, the use thereof for the treatment of diseases, and precursors
07/25/1989US4851436 HMG-CoA reductase inhibitors
07/25/1989US4851431 Physiologically active and nutritional composition
07/25/1989US4851413 Certain benzoquinones, naphthoquinones, corresponding hydroquinones which exhibit thromboxane A2 synthetase inhibition or receptor antagonism and the like
07/25/1989US4851410 Antisecretory, histamine h2-antagonists
07/25/1989US4851408 Use of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazol[5,4-d]azepine for releasing growth hormone
07/25/1989US4851402 Feed utilization efficiency, ruminant
07/25/1989US4851401 Novel cyclopentano-vitamin D analogs
07/25/1989US4851224 Drying the precipitated acetylated mannose-based polysaccharid e obtained by adding a solvent to acidified aloe juice from th e leaf
07/25/1989US4851221 Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid
07/25/1989CA1257837A1 Topical pharmaceutical compositions
07/20/1989DE3900233A1 Isoquinoline derivatives and their use
07/19/1989EP0324574A2 Immunomodulating bryostatins
07/19/1989EP0324447A2 Means and process for producing a recombinant human interleukin-1 alpha polypeptide
07/19/1989EP0324421A2 Phosporus-containing squalene synthetase inhibitors, new intermediates and method
07/19/1989EP0324227A1 A composition of matter for increasing intracellular atp levels and physical performance levels and for increasing the rate of wound repair
07/19/1989EP0324023A1 Thiosulphinic acid derivatives, their use in the treatment of inflammatory diseases, and drugs containing them
07/19/1989CN1033995A Aromatase inhibiting 4(5)-imidazoles
07/18/1989US4849525 Phosphinylcycloalkylcarbonyl and phosphinylcycloalkenylcarbonyl dipeptides
07/18/1989US4849454 Decyclization, dehydrogenation
07/18/1989US4849451 Fat emulsion containing prostaglandin
07/18/1989US4849431 Piperidine derivative and pharmaceutical composition
07/18/1989US4849416 Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
07/18/1989US4849406 Aprotinin
07/13/1989WO1989006139A1 Reduction of side effects of cancer therapy
07/13/1989WO1989006128A1 2-CARBOXYALKYLTHIOIMIDAZOLES AND ESTERS THEREOF AS DOPAMINE-beta-HYDROXYLASE INHIBITORS
07/13/1989WO1989006126A1 1-ARALKYL-2-MERCAPTOIMIDAZOLINES AS DOPAMINE-beta-HYDROXYLASE INHIBITORS
07/13/1989WO1989006125A1 4-aralkyl-5-substituted-1,2,4-triazole-5-thiols
07/12/1989EP0323737A1 4-Aralkyl-5-substituted-1,2,4-triazole-5-thiols
07/12/1989CN1033802A Derivatives of cysteine
07/11/1989US4847305 Phenolic thioethers as inhibitors of 5-lipoxygenase
07/11/1989US4847299 Bone disorders
07/11/1989US4847297 Aids treatment
07/11/1989US4847295 Cycloalkyl-substituted 4-aminophenyl halo derivatives and process for their preparation
07/11/1989US4847268 8-phenylthio-tetrahydroquinolines and anti-allergic use thereof
07/11/1989US4847263 Imidazopyridine derivatives and compositions containing them
07/11/1989US4847254 CNS affecting 5-oxy-3-aminomethyl-dihydro-benzofurans and benzothiophenes
07/11/1989US4847253 Extrapyramidal syndromes
07/11/1989CA1257289A1 1-substituted 4-methoxy-2,3,6-trimethylbenzene derivatives; process for preparing the same and their use as cosmetics
07/11/1989CA1257285A1 7-oxabicycloheptane substituted oxa prostaglandin analogs
07/11/1989CA1257273A1 Indole derivatives
07/11/1989CA1257272A1 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
07/11/1989CA1257269A1 Furo-(3,4-c)-pyridine derivatives preparation thereof and therapeutic compositions containing the same
07/11/1989CA1257258A1 Bicyclic heterocyclyl containing n-(bicyclic heterocyclyl)-4-piperidinamines
07/05/1989EP0323146A2 Dopamine-beta-hydroxylase inhibitors
07/05/1989EP0323077A1 Heterocyclic compounds
07/05/1989EP0322914A2 Novel sulfhydryl containing tricyclic lactams and their pharmacological methods of use
07/05/1989EP0322795A2 Novel tetrapyrrole aminocarboxylic acids
07/05/1989EP0322738A2 Benzylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells
07/04/1989US4845115 Cognitive disorders
07/04/1989US4845113 2-substituted -1,4-dihydropyridines and pharmaceutical compositions containing them
07/04/1989US4845110 Antagonist effect on leukotriene receptors
07/04/1989CA1256889A1 7-oxabicycloheptane substituted ethers
07/04/1989CA1256888A1 7-oxabicycloheptane substituted oxa prostaglandin analogs
07/04/1989CA1256874A1 Cardioselective aryloxy and arylthio-hydroxypropyl piperazinyl acetanilides which affect calcium entry
07/04/1989CA1256867A1 1,2-benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives
06/1989
06/29/1989WO1989005822A1 Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2)
06/29/1989WO1989005793A1 N-acyl-n-naphthoylglycines as aldose reductase inhibitors
06/29/1989WO1989005791A1 N-naphthoylglycines as aldose reductase inhibitors
06/29/1989WO1989005656A1 Wound healing
06/29/1989WO1989005653A1 Topical wound-healing preparations comprising interleukin-1 proteins
06/29/1989WO1989005646A1 Uses of sulphated sugars
06/29/1989WO1989005645A1 Use of sucralfate
06/29/1989WO1989005641A1 Dextromethorphan potentiator for anticonvulsant composition and method
06/29/1989WO1989005640A1 Pharmaceutical compositions
06/29/1989WO1989005639A1 NOVEL HMG-CoA REDUCTASE INHIBITORS
06/29/1989WO1989005637A1 Improving toxicity profiles in chemotherapy
06/28/1989EP0322256A1 N-acyl-N-naphthoylglycines as aldose reductase inhibitors
06/28/1989EP0322255A1 N-acyl-N-naphthoylglycines as aldose reductase inhibitors
06/28/1989EP0322226A2 Site-directed mutagenesis modified glycoprotein hormones and methods of use
06/28/1989EP0322184A2 N-(2-Alkyl-3-mercapto-1,5-di-oxoalkyl)glycinamide derivatives and their use as collagenase inhibitors
06/28/1989EP0322094A1 N-terminal fragments of human serum albumin
06/28/1989EP0322048A1 Pharmaceutical compositions
06/28/1989EP0322020A1 Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis
06/28/1989EP0322016A1 1,7-Annelated indolecarboxylic acid esters and -amides
1 ... 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 ... 1564